To The Moon

$NVIDIA(NVDA)$ and $Advanced Micro Devices(AMD)$  both fell for a fourth consecutive session on Monday, despite announcing new designs for future AI data centres.  The problem isn’t necessarily a lack of innovation. It’s timing. 🚀 Nvidia is building for the next generation Nvidia announced open-standard designs for its upcoming Vera Rubin AI platform, working with partners including Meta, Cisco and Google. AMD introduced its Helios rack blueprint, designed to support advanced AI workloads and give partners more flexibility to build their own systems. Both companies are positioning themselves for the next stage of AI infrastructure. But much of the potential revenue remains in the future, ra

Hello everyone! Today i want to share some trading strategies with you! There's a high probability tomorrow will be another consolidation day before CPI data on Wednesday morning. DO NOT get caught up trading the chop. This is how you bleed out your account. IF $SPX fails to hold 7800 and $Invesco QQQ(QQQ)$ stays under 748 there's no reason to be aggressively trading the upside. Wait for the reaction to CPI then execute. We're still seeing a rotation into $Meta Platforms, Inc.(META)$ $Microsoft(MSFT)$ $Alphabet(GOOGL)$

Questions are finally starting to be asked about the AI trade, and the answers may not please some. Longtime readers know the AI trade is something I’ve generally stayed away from. We’re seeing trillions of dollars invested in AI technology that hasn’t proven (yet) to have a sustainable business model. My argument isn’t that it’s not valuable, but rather that we’re likely to over-invest, get a correction (the bubble pops), and then the opportunity for long-term gains comes in the wreckage. In other words, the “Trough of Disillusionment” is my sweet spot, which I explained in this 2024 article. I’m not predicting the bubble bursting yet. But I’m not going to get in front of that train, holding the bag when it does. And the past week has seen most of the AI infrastructure (bottleneck) stocks

When markets focus on technology and AI, healthcare can offer a different investment story. Today, I’m watching $JNJ (Johnson & Johnson) as it prepares to report quarterly earnings. 🩺 What does Johnson & Johnson do? Johnson & Johnson is a global healthcare company operating in two main areas: 💊 Innovative Medicine: Prescription medicines for cancer, immune disorders and other serious conditions. 🦾 MedTech: Medical devices and technologies used in surgery, cardiovascular care and other procedures. 📊 Why watch it today? 1. Earnings are in focus Investors will be looking for revenue growth, earnings performance and management’s outlook. Strong results could support the stock, but even good numbers may disappoint if expectations are too high. 2. A different kind of growth story Hea

$MU, $SNDK and $SK Hynix have faced selling pressure, but the memory market tells a more complicated story than simply saying AI demand is strong or conventional DRAM is oversupplied. The real issue is whether strong demand can translate into sustainable earnings growth. 🔍 Three signals I’m watching 1️⃣ Memory prices: Still rising, but the pace matters TrendForce forecast conventional DRAM contract prices to rise 10–15% quarter over quarter in Q4 2026. That points to continued pricing strength, but investors also need to watch whether increases slow. If memory prices stop rising, earnings expectations could come under pressure even if demand remains healthy. 2️⃣ AI demand isn’t the whole memory market High-bandwidth memory (HBM) is essential for AI accelerators, while server DRAM supports

📊 Market Recap As of October 13, 2026, 'COHR' closed at $288.02, tumbling -7.87% with a daily amplitude of 7.01%. The stock sits roughly 34.5% below its 52-week high of $440.00, breaking below the recent support zone and signaling a sharp risk-off move following strong gains earlier in the month. 🚀 Key Drivers AI/Photonics Sentiment Reset：High-valuation semiconductor and optical names faced broad pressure as investors reassessed near-term AI infrastructure spending momentum. Profit-Taking After Rally：'COHR' had built substantial momentum in prior weeks; the -7.87% drop reflects aggressive de-risking after the stock approached the $340 resistance area. Macro Risk Appetite Cooling：Broader market caution and rotation away from extended growth/tech names contributed to outsized downside in hig

📊 Market Recap As of the latest close on October 13, 2026, 'NVDA' settled at $226.32, down -1.29% on the day. The stock is now roughly 7.0% below its 52-week high of $243.37, yet still sits far above its 52-week low of $164.27. Recent sessions show fading upside momentum as price consolidates below the $233 resistance zone. 🚀 Key Drivers AI Capex Momentum: Sustained enterprise demand for high-end AI chips continues to underpin the fundamental growth narrative across the semiconductor supply chain. IPO Sentiment Ripple: Reports that NVIDIA-backed data center firm Firmus Grid is delaying its IPO have slightly cooled sentiment around AI infrastructure monetization timelines. Broader Tech Consolidation: After strong index-level gains, US tech leadership is pausing, and high-multiple AI names l

📊 Market Recap As of the close on October 13, 2026, 'SOXL' finished at $128.40, a sharp decline of -8.13% (-$11.36). The ETF closed just above its intraday low of $127.27 and remains approximately 57.5% below its 52-week high of $302.00, reflecting intense selling pressure in the semiconductor sector. Pre-market indications of $134.30 failed to hold, with heavy selling dominating the session. 🚀 Key Drivers Semiconductor Momentum Collapse: The 3x leveraged structure of 'SOXL' amplified downside moves as underlying semiconductor indices faced a risk-off environment, erasing recent gains. Leverage Decay & Volatility: With a daily amplitude of 5.20% and heavy turnover (36.65%), the fund experienced accelerated NAV erosion typical of high-beta instruments during drawdowns. Capital Outflow P

$HOOD 20261016 130.0 CALL$ Limit order filled during Hood price recovery to sell covered call at strike $130 psychological resistance.

$NFLX 20261023 63.0 PUT$ Earnings play Be water, my friend—stay calm, adapt, and let the market do its thing. Watch me pocket $15K in premiums in Oct. Jun/Jul/Aug/Sep: $1,721/$26,431/$34,103/$26,671 Oct 2026: $5,012

$ASTS 20261016 71.0 CALL$ Limit order filled to short ASTS call on market open due to positive news .

$Lululemon Athletica(LULU)$ Another early assignment. Intend to sell covered call later to bring down my cost price [Cool]  

$LLY 20270115 1140.0 CALL$ Traded the technicals on Eli Lilly ($LLY) after tracking its massive intraday swings over the last few weeks. We’ve seen single-session expansions as high as 5.17% (a massive ~$60 range), which opens up incredible short-term windows if you time the entries right. The Strategy: * The Entry: Waited patiently for the share price to dip down toward the support side of its current ascending channel. * The Exit: Locked in profits cleanly as soon as the price bounced and hit key overhead resistance EMAs. In and out in just 2 days. When a high-beta large-cap moves this fast, sticking strictly to the daily levels makes for a highly tactical—and exciting—trade. On to the next setup!